These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neuropilin-1 modulates vascular endothelial growth factor-induced poly(ADP-ribose)-polymerase leading to reduced cerebrovascular apoptosis. Mey L; Hörmann M; Schleicher N; Reuter P; Dönges S; Kinscherf R; Gassmann M; Gerriets T; Al-Fakhri N Neurobiol Dis; 2013 Nov; 59():111-25. PubMed ID: 23816753 [TBL] [Abstract][Full Text] [Related]
3. FGF2-mediated upregulation of urokinase-type plasminogen activator expression requires a MAP-kinase dependent activation of poly(ADP-ribose) polymerase. Caldini R; Barletta E; Del Rosso M; Giovannelli L; Chevanne M J Cell Physiol; 2005 Jan; 202(1):125-34. PubMed ID: 15389540 [TBL] [Abstract][Full Text] [Related]
4. Regulation of vascular endothelial growth factor expression by insulin-like growth factor-II in human keratinocytes, differential involvement of mitogen-activated protein kinases and feedback inhibition of protein kinase C. Kim HJ; Kim TY Br J Dermatol; 2005 Mar; 152(3):418-25. PubMed ID: 15787809 [TBL] [Abstract][Full Text] [Related]
5. The WT1 Wilms' tumor suppressor gene is a downstream target for insulin-like growth factor-I (IGF-I) action in PC12 cells. Sarfstein R; Werner H J Neurochem; 2006 Nov; 99(3):818-26. PubMed ID: 16911581 [TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells. Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835 [TBL] [Abstract][Full Text] [Related]
7. Endothelial cell response to lactate: implication of PAR modification of VEGF. Kumar VB; Viji RI; Kiran MS; Sudhakaran PR J Cell Physiol; 2007 May; 211(2):477-85. PubMed ID: 17167776 [TBL] [Abstract][Full Text] [Related]
8. Effects of 7-ketocholesterol on the activity of endothelial poly(ADP-ribose) polymerase and on endothelium-dependent relaxant function. Kiss L; Chen M; Gero D; Módis K; Lacza Z; Szabó C Int J Mol Med; 2006 Dec; 18(6):1113-7. PubMed ID: 17089016 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of angiogenesis by the poly(ADP-ribose) polymerase inhibitor PJ-34. Pyriochou A; Olah G; Deitch EA; Szabó C; Papapetropoulos A Int J Mol Med; 2008 Jul; 22(1):113-8. PubMed ID: 18575783 [TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts. García S; Bodaño A; Pablos JL; Gómez-Reino JJ; Conde C Ann Rheum Dis; 2008 May; 67(5):631-7. PubMed ID: 17890271 [TBL] [Abstract][Full Text] [Related]